Bipolar disorder is characterized by bouts of extreme mood, with episodes of mania occurring alongside periods of depression.

Vanda Pharmaceuticals announces the FDA approval of iloperidone (Fanapt) for the acute treatment of bipolar 1 disorder. Iloperidone is a second-generation atypical antipsychotic agent for managing ...

"Next session meets July 6-September 21, 2022. This group is for adults (18+) who have difficulty managing their moods, emotions, relationships and behaviors. In the context of a warm and ...

Lizzie Duszynski-Goodman is a journalist living in the Midwest with her husband and two young children. Her work explores the intersection of mental health, wellness and parenting. She is the former ...

Findings published in Biological Psychiatry point to new therapeutic pathways to protect this at-risk population from heart failure and improve life expectancy Despite accumulating evidence that ...

Cardiovascular disease is the leading cause of premature deaths in patients with bipolar disorder worldwide. In a novel study in young adults (aged 20–45) with bipolar disorder, researchers were able ...

I specialize in helping individuals who are struggling with depression, bipolar disorder, borderline personality disorder (BPD), and substance abuse. I use evidence-based therapies like Dialectical ...

(RTTNews) - Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), in collaboration with Medincell (MEDCL.PA), announced that the U.S. Food and Drug Administration has ...